Clinical Trial Update: Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV [NA]

View source ↗

Summary

A completed clinical trial evaluated whether adding interleukin-2 to standard anti-HIV therapy improves outcomes in individuals recently infected with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Antiretroviral therapy
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | NA | Status: COMPLETED